Market experts have issued a strong buy recommendation for Apollo Hospitals Enterprise Ltd. with a current market price of ₹8,967. According to Avinash Gorakshakar, Director, Research Profitmart Securities, the stock could be considered a very good defensive bet with earnings growth potential of up to 20%. The recommendation is based on the company's promising prospects in the healthcare sector and its defensive characteristics during market volatility. As per Rajesh Bhosale, Senior Technical Analyst, My Advisor Alpha, the stock is recommended for aggressive buying at current levels, with the potential for significant earnings growth making it an attractive investment opportunity. The company operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments, offering comprehensive healthcare services including cardiac sciences, oncology, neurosciences, and specialized medical procedures.
Torrent Pharmaceuticals Ltd. is recommended as a buy on dips with a current market price of ₹4,930. As reported by Gorakshakar, the stock looks interesting at the current point in time and can be considered for buying on market dips. The pharmaceutical company's positioning in the healthcare sector makes it an attractive investment opportunity for investors looking to add to their portfolio. According to Bhosale, the stock is currently interesting and investors should consider adding to their positions at current levels.
Global Health Ltd is currently trading at ₹1,479.75 on both NSE and BSE, showing strong performance with a 34.40% increase over the past six months and 9.13% growth over the last year. The stock has recorded a 52-week high of ₹1,542.00 and a 52-week low of ₹955.20, with the current market capitalization standing at approximately ₹39,786 crore. The company's P/E ratio is 58.06 and P/B ratio is 8.05, reflecting strong market valuation metrics. Over the past three years, Global Health Ltd has delivered an impressive return of approximately 112.65%, significantly outperforming broader market indices. The shareholding pattern as of June 2026 shows 33.00% promoters, 16.89% DIIs, 5.60% public shareholders, and -6.57% FIIs.
Indo-MIM is advised for accumulation via systematic investment plan (SIP) with a current market price of ₹984.55. According to Gorakshakar, the company is a market leader in the metallic forging industry with a strong clientele base. The recommendation suggests an SIP approach due to the company's market leadership position and established client relationships in the industrial sector. As per Bhosale, the company can be accumulated via SIP due to its strong fundamentals and market position.
Mahindra & Mahindra Ltd. is recommended as a buy with a current market price of ₹3,150. As reported by Gorakshakar, the stock is considered a much better option compared to Maruti Suzuki and benefits from the utility vehicle business and electric vehicle portfolio. The positive outlook is based on the company's strong positioning in the utility vehicle segment and its EV initiatives. However, Bhosale suggests that investors should not add more to their positions at current levels, as the stock has reached attractive valuations. The recommendation emphasizes the company's superior positioning in the utility vehicle space compared to competitors.
